Cencora(DE:ABG)
€316.60+4.80 (+1.54%)
DE:ABG
Cencora stock forecast
€316.60
At close:+4.80 (+1.54%)
Cencora (ABG) Stock Forecast & Price Target
1 Followers
ABG Analyst Ratings
Strong Buy
8Buy2Hold0Sell
Based on 10 analysts giving stock ratings to Cencora in the past 3 months
ABG Stock 12 Month Forecast
Average Price Target
€338.60▲(6.95% Upside)Based on 10 Wall Street analysts offering 12 month price targets for Cencora in the last 3 months. The average price target is EUR 338.60 with a high forecast of EUR 368.00 and a low forecast of EUR 294.04. The average price target represents a 6.95% change from the last price of EUR 316.60.
Past 12 Months12 Month ForecastJan2026Oct2026
High€368.00
Average€338.60
Low€294.04
Highest Price TargetHighest€368.00Average Price Target€338.60Lowest Price TargetLowest€294.04
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Lisa Gill | J.P. Morgan | €347.51→€368.00 | buy | 16.23%Upside | Reiterated | 11/10/26 | ||
| Allen Lutz | Bank of America Securities | €320.77 | hold | 1.32%Upside | Reiterated | 11/10/26 | ||
| Glen Santangelo | Barclays | €311.86 | buy | -1.50%Downside | Reiterated | 11/05/26 | ||
| Eric Coldwell | Robert W. Baird | €334.14→€360.87 | buy | 13.98%Upside | Reiterated | 11/05/26 | ||
| Ryan Halsted | RBC Capital | €294.04 | hold | -7.12%Downside | Reiterated | 11/05/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | €311.86→€338.60 | buy | 6.95%Upside | Reiterated | 11/05/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | €345.72→€360.87 | buy | 13.98%Upside | Reiterated | 11/05/26 | ||
| Erin Wright | Morgan Stanley | €308.30→€335.92 | buy | 6.10%Upside | Assigned | 10/30/26 | ||
| David Toung | Argus Research | €302.95→€338.60 | buy | 6.95%Upside | Reiterated | 10/20/26 | ||
| Kevin Caliendo | UBS | €383.15→€356.42 | buy | 12.58%Upside | Reiterated | 10/16/26 | ||
| Stephen Baxter | Wells Fargo | €294.93→€351.96 | buy | 11.17%Upside | Assigned | 08/11/26 | ||
| Charles Rhyee | TD Cowen | €356.42 | buy | 12.58%Upside | Reiterated | 08/09/26 | ||
| Daniel Grosslight | Citi | €316.32→€329.68 | buy | 4.13%Upside | Reiterated | 08/06/26 | ||
| Ryan Daniels | William Blair | ― | hold | ― | Reiterated | 08/05/26 | ||
| Brian Tanquilut | Jefferies | €294.04→€392.06 | buy | 23.83%Upside | Upgraded | 01/22/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Lisa GillJ.P. Morgan | BuyReiterated€347.51→€368.00 | 11/10/26 | 16.23%Upside | ||
| Allen LutzBank of America Securities | HoldReiterated€320.77 | 11/10/26 | 1.32%Upside | ||
| Glen SantangeloBarclays | BuyReiterated€311.86 | 11/05/26 | -1.50%Downside | ||
| Eric ColdwellRobert W. Baird | BuyReiterated€334.14→€360.87 | 11/05/26 | 13.98%Upside | ||
| Ryan HalstedRBC Capital | HoldReiterated€294.04 | 11/05/26 | -7.12%Downside | ||
| Elizabeth Anderson CFAEvercore ISI | BuyReiterated€311.86→€338.60 | 11/05/26 | 6.95%Upside | ||
| Unknown AnalystLeerink PartnersNot Ranked | BuyReiterated€345.72→€360.87 | 11/05/26 | 13.98%Upside | ||
| Erin WrightMorgan Stanley | BuyAssigned€308.30→€335.92 | 10/30/26 | 6.10%Upside | ||
| David ToungArgus Research | BuyReiterated€302.95→€338.60 | 10/20/26 | 6.95%Upside | ||
| Kevin CaliendoUBS | BuyReiterated€383.15→€356.42 | 10/16/26 | 12.58%Upside | ||
| Stephen BaxterWells Fargo | BuyAssigned€294.93→€351.96 | 08/11/26 | 11.17%Upside | ||
| Charles RhyeeTD Cowen | BuyReiterated€356.42 | 08/09/26 | 12.58%Upside | ||
| Daniel GrosslightCiti | BuyReiterated€316.32→€329.68 | 08/06/26 | 4.13%Upside | ||
| Ryan DanielsWilliam Blair | HoldReiterated | 08/05/26 | ― | ||
| Brian TanquilutJefferies | BuyUpgraded€294.04→€392.06 | 01/22/26 | 23.83%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Cencora
3 Months
Success Rate26/38 ratings generated profit
68%
Average Return
+5.28%
Copying Charles Rhyee's trades and holding each position for 3 Months would result in 68.42% of your transactions generating a profit, with an average return of +5.28% per trade.
1 Year
Success Rate40/48 ratings generated profit
83%
Average Return
+22.10%
Copying Eric Coldwell's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +22.10% per trade.
2 Years
Success Rate35/38 ratings generated profit
92%
Average Return
+38.42%
Copying Charles Rhyee's trades and holding each position for 2 Years would result in 92.11% of your transactions generating a profit, with an average return of +38.42% per trade.
ABG Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 1 | 0 | 0 | 0 |
| Buy | 9 | 12 | 11 | 16 | 10 |
| Hold | 8 | 8 | 8 | 7 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 21 | 21 | 19 | 23 | 16 |
In the current month, ABG has received 10 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. ABG average Analyst price target in the past 3 months is 338.60.
ABG Financial Forecast
High€4.45
Consensus€4.11
Low€3.91
ABG Earnings Forecast
Next quarter’s earnings estimate for ABG is EUR 4.11 with a range of EUR 3.91 to EUR 4.45. The previous quarter’s EPS was EUR 4.20. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€82.1B
Consensus€81.5B
Low€81B
ABG Sales Forecast
Next quarter’s sales forecast for ABG is EUR 81.52B with a range of EUR 81.04B to EUR 82.08B. The previous quarter’s sales results were EUR 79.62B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
ABG Stock Forecast FAQ
What is DE:ABG’s average 12-month price target, according to analysts?
Based on analyst ratings, Cencora’s 12-month average price target is €338.60.
What is DE:ABG’s upside potential, based on the analysts’ average price target?
Cencora has 6.95% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cencora a Buy, Sell or Hold?
Cencora has a consensus rating of Strong Buy, which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.
What is Cencora’s share price target?
The average share price target for Cencora is €338.60. This is based on 10 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €368.00, and the lowest forecast is €294.04. The average share price target represents a 6.95% increase from the current price of €316.6.
What do analysts say about Cencora?
Cencora’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of Cencora?
To buy shares of DE:ABG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
